NRAA Encourages FDA to Act to Resolve Saline Shortage

On September 5, Fresenius Medical Care North America announced a temporary shortage of 1-liter normal saline product. The shortage is due to an issue with Customs affecting their production facility in Guadalajara, Mexico. While Fresenius states that the shortage is only temporary, yesterday the NRAA sent a letter to the FDA encouraging them to help make sure the matter is resolved both safely and expeditiously. In response, the FDA stated their belief that the shortage issue has been resolved. The NRAA encourages members to continue to look for alternative sources of saline while the resolution process is taking place.
 
Please click here to view the Fresenius letter announcing the saline shortage and here to view the NRAA's letter to the FDA.

Additional information